Live from the NIH registry
Studies recruiting near Columbus right now
Top 25 of 67 recruiting studies, sorted by proximity — each links to its official registry page
Deep Neural Network Stratification for Use Detecting Endometriosis in Women Affected by Chronic Pelvic Pain (EndoCheck)
Endometriosis
N/A
Observational 1,200 participants sought
Midtown OBGYN North — Columbus, Georgia (7.3 mi)
· Sponsor: Aspira Women's Health
A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions.
Ankle Arthrodesis or Arthroplasty, Hindfoot Fusion
N/A
Interventional 126 participants sought
Hughston Foundation Inc — Columbus, Georgia (7.3 mi)
· Sponsor: Kuros Biosurgery AG
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Breast Cancer, Early Breast Cancer
Phase 3
Interventional 4,300 participants sought
Research Site — Columbus, Georgia (7.3 mi)
· Sponsor: AstraZeneca
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
Primary Membranous Nephropathy
Phase 2, Phase 3
Interventional 176 participants sought
DaVita Clinical Research Columbus — Columbus, Georgia (7.3 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
AETOS Shoulder System
Shoulder Osteoarthritis, Shoulder Arthritis
N/A
Observational 220 participants sought
Hughston Foundation — Columbus, Georgia (7.3 mi)
· Sponsor: Smith & Nephew, Inc.
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
IACT Health-Brookstone Centre Pkwy — Columbus, Georgia (7.3 mi)
· Sponsor: Sparrow Pharmaceuticals
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Non Small Cell Lung Cancer
Phase 3
Interventional 780 participants sought
Centricity Research Columbus Cancer Center ( Site 0005) — Columbus, Georgia (7.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Overweight, Obesity
Phase 3
Interventional 460 participants sought
Columbus Research Foundation — Columbus, Georgia (7.3 mi)
· Sponsor: Novo Nordisk A/S
Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects
Asthma
N/A
Observational 160 participants sought
AllerVie Clinical Research — Columbus, Georgia (7.3 mi)
· Sponsor: Biometry Inc
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Columbus, Georgia (7.3 mi)
· Sponsor: Akero Therapeutics, Inc
Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease
APOL1-Mediated Kidney Disease
Phase 2
Interventional 136 participants sought
Research Site — Columbus, Georgia (7.3 mi)
· Sponsor: AstraZeneca
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Type 2 Diabetes
Phase 3
Interventional 55 participants sought
Centricity Research Columbus Endocrinology — Columbus, Georgia (7.3 mi)
· Sponsor: Eli Lilly and Company
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
Locally Advanced Pancreatic Cancer
Phase 3
Interventional 190 participants sought
Piedmont-Columbus Regional - John B. Amos Cancer Center — Columbus, Georgia (7.3 mi)
· Sponsor: RenovoRx
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Graves' Disease
Phase 2
Interventional 210 participants sought
Site Number - 1020 — Columbus, Georgia (7.3 mi)
· Sponsor: Immunovant Sciences GmbH
An Internet-based Program to Help Cancer Survivors Manage Pain
Cancer
N/A
Interventional 456 participants sought
John B. Amos Cancer Center — Columbus, Georgia (7.3 mi)
· Sponsor: Wake Forest University Health Sciences
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 1
Interventional 24 participants sought
Lane Dermatology and Dermatologic Surgery — Columbus, Georgia (7.3 mi)
· Sponsor: Incyte Corporation
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
Hypertension, Uncontrolled Hypertension
Phase 2
Interventional 240 participants sought
Vanda Investigative Site — Columbus, Georgia (7.3 mi)
· Sponsor: Vanda Pharmaceuticals
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Alzheimer's Disease
Phase 3
Interventional 586 participants sought
Local Institution - 0016 — Columbus, Georgia (7.3 mi)
· Sponsor: Bristol-Myers Squibb
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus, T2DM
Phase 2
Interventional 180 participants sought
Centricity Research IRT - DBA IACT Health Columbus Piedmont — Columbus, Georgia (7.3 mi)
· Sponsor: Hanmi Pharmaceutical Company Limited
A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer
Diabetic Foot Ulcer, Foot Ulcer
Phase 3
Interventional 230 participants sought
IACT Health — Columbus, Georgia (7.3 mi)
· Sponsor: Energenesis Biomedical Co., Ltd.
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis
Phase 2
Interventional 300 participants sought
Columbus Memory Center — Columbus, Georgia (7.3 mi)
· Sponsor: Lighthouse Pharmaceuticals, Inc.
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
Contraception
N/A
Interventional 573 participants sought
Midtown OB GYN North — Columbus, Georgia (7.3 mi)
· Sponsor: Femasys Inc.
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 500 participants sought
John B Amos Cancer Center — Columbus, Georgia (7.3 mi)
· Sponsor: Bristol-Myers Squibb
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Melanoma
Phase 3
Interventional 560 participants sought
John B. Amos Cancer Center — Columbus, Georgia (7.3 mi)
· Sponsor: Regeneron Pharmaceuticals
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
Phase 3
Interventional 11,300 participants sought
Research Site — Columbus, Georgia (7.3 mi)
· Sponsor: AstraZeneca